98%
921
2 minutes
20
Background: To develop and validate a nomogram model based on Gd-EOB-DTPA enhanced MRI for differentiation between hepatocellular carcinoma (HCC) and focal nodular hyperplasia (FNH) showing iso- or hyperintensity in the hepatobiliary phase (HBP).
Methods: A total of 75 patients with 49 HCCs and 26 FNHs randomly divided into a training cohort (n = 52: 34 HCC; 18 FNH) and an internal validation cohort (n = 23: 15 HCC; 8 FNH). A total of 37 patients (n = 37: 25 HCC; 12 FNH) acted as an external test cohort. The clinical and imaging characteristics between HCC and FNH groups in the training cohort were compared. The statistically significant parameters were included into the FAE software, and a multivariate logistic regression classifier was used to identify independent predictors and establish a nomogram model. Receiver operating characteristic (ROC) curves were used to evaluate the prediction ability of the model, while the calibration and decision curves were used for model validation. Subanalysis was used to compare qualitative and quantitative characteristics of patients with chronic hepatitis and cirrhosis between the HCC and FNH groups.
Results: In the training cohort, gender, age, enhancement rate in the arterial phase (AP), focal defects in uptake were significant predictors for HCC showing iso- or hyperintensity in the HBP. In the training cohort, area under the curve (AUC), sensitivity and specificity of the nomogram model were 0.989(95%CI: 0.967-1.000), 97.1% and 94.4%. In the internal validation cohort, the above three indicators were 0.917(95%CI: 0.782-1.000), 93.3% and 87.5%. In the external test cohort, the above three indicators were 0.960(95%CI: 0.905-1.000), 84.0% and 100.0%. The results of subanalysis showed that age was the independent predictor in the patients with chronic hepatitis and cirrhosis between HCC and FNH groups.
Conclusions: Gd-EOB-DTPA enhanced MRI nomogram model may be useful for discriminating HCC and FNH showing iso- or hyperintensity in the HBP before surgery.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11320848 | PMC |
http://dx.doi.org/10.1186/s12880-024-01382-6 | DOI Listing |
Quant Imaging Med Surg
September 2025
Department of Radiology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
Background: Magnetic resonance imaging (MRI) plays a crucial role in the diagnosis of abdominal conditions. A comprehensive assessment, especially of the liver, requires multi-planar T2-weighted sequences. To mitigate the effect of respiratory motion on image quality, the combination of acquisition and reconstruction with motion suppression (ARMS) and respiratory triggering (RT) is commonly employed.
View Article and Find Full Text PDFDiagnostics (Basel)
August 2025
Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
As a noninvasive indicator of liver fibrosis and stiffness, liver stiffness measurement (LSM) has also shown significant value in differentiating focal liver lesions (FLLs). This study aimed to assess the characteristics of LSM values across different liver lesions and explore their value in differential diagnosis. A total of 8817 individuals with FLLs were assessed using liver stiffness measurements (LSMs).
View Article and Find Full Text PDFAbdom Radiol (NY)
August 2025
Department of Radiology, Hamamatsu University School of Medicine, 1-20-1, Handayama, Chuo-ku, Hamamatsu City, Shizuoka, 431-3192, Japan.
Hepatobiliary (HB)-specific magnetic resonance imaging (MRI) contrast agents, particularly gadoxetic acid, are being increasingly utilized for liver imaging, with well-established clinical utility. The most distinctive feature of gadoxetic acid is HB phase imaging performed 20 min after administration. In clinical practice, most focal liver lesions lack gadoxetic acid uptake and appear hypointense against the background of normally enhancing liver parenchyma owing to the absence of hepatocyte function within the tumor tissue.
View Article and Find Full Text PDFClin J Gastroenterol
July 2025
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Patients with decompensated cirrhosis complicated by hepatocellular carcinoma (HCC) or those who have undergone liver transplantation following liver failure after HCC treatment should continue to receive post-transplant surveillance. Any new liver tumor must be carefully evaluated to determine whether it is a recurrence of HCC. Focal nodular hyperplasia (FNH), the second most common benign hepatic tumor, is believed to result from the hyperplastic response of hepatocytes to pre-existing vascular malformation.
View Article and Find Full Text PDFJ Gastrointest Oncol
June 2025
Department of Imaging and Interventional Radiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
Background: Focal nodular hyperplasia (FNH) and liver cancers are commonly differentiated by contrast enhanced scan, particularly with the application of hepatobiliary-specific contrast agents. This study aims to investigate the diffusion-derived vessel density (DDVD) difference between liver FNH and liver malignant lesions [hepatocellular carcinoma (HCC) and metastasis].
Methods: The liver diffusion-weighted magnetic resonance imaging (MRI) dataset-1 had 8 cases of FNH, 56 cases of HCC, and 14 cases of liver metastases.